Loading clinical trials...
Loading clinical trials...
We aim to assess the usefulness of systematic reinterpretation of CNV of unknown significance. To investigate this question we will study all CNV of unknown significance detected between 2010 and 2017...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Central Hospital, Nancy, France
NCT00001405 · Granuloma, Granulomatous Disease, Chronic, and more
NCT07039084 · Genetic Disease, Nonverbal Communication, and more
NCT00001373 · Familial Mediterranean Fever (FMF), Autoinflammation, and more
NCT05407636 · AMD, nAMD, and more
NCT06672237 · Neuromuscular Disease, Neuromuscular Diseases (NMD), and more
Lorraine University
Nancy
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions